Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 3/20 | 0.70 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DDO | Q99489 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 2/20 | 0.45 |
| ▸ | RXRB | P28702 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30269665 | 1.00 | TPMT (0.70) | TPMTHCAR1CYP3A4TP53KDM4E | |
| Hydrochloric Acid SCHEMBL3779663 | 0.98 | TPMT (0.67) | TPMTHCAR1CYP3A4TP53KDM4E | |
| SCHEMBL7189753 | 0.84 | CYP3A4 (0.55) | TPMTHCAR1CYP3A4TP53KDM4E | |
| SCHEMBL28214359 | 0.83 | TPMT (1.00) | TPMTHCAR1TP53KDM4EALDH1A1 | |
| SCHEMBL2820215 | 0.83 | KDM4E (0.56) | TPMTTP53KDM4EALDH1A1LMNA | |
| SCHEMBL223304 | 0.83 | KDM4E (0.56) | TPMTTP53KDM4EALDH1A1LMNA | |
| SCHEMBL69625 | 0.83 | TPMT (0.89) | TPMTHCAR1TP53KDM4EALDH1A1 | |
| SCHEMBL109155 | 0.83 | KDM4E (0.56) | TPMTHCAR1TP53KDM4EALDH1A1 | |
| SCHEMBL23699 | 0.83 | TPMT (1.00) | TPMTHCAR1TP53KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL9311860 | 0.80 | KDM4E (0.54) | TPMTTP53KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118459988-B | High-modulus carbon fiber nylon composite material and preparation method thereof | 烟台奥森制动材料有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118459988-A | High-modulus carbon fiber nylon composite material and preparation method thereof | 烟台奥森制动材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| EP-2890800-B1 | CONTINUOUS BIOTRANSFORMATION OF SUBSTITUTED AROMATIC CARBOXYLIC ACIDS TO THEIR CORRESPONDING ALDEHYDES AND ALCOHOLS | PRIVI BIOTECHNOLOGIES PVT LTD (IN) | 2020-12-16 | — | — | EP | claimed |
| US-10017797-B2 | Continuous biotransformation of substituted aromatic carboxylic acids to their selective aldehydes and alcohols | PRIVI BIOTECHNOLOGIES PRIVATE LIMITED (IN) | 2018-07-10 | — | — | US | claimed |
| US-20150252397-A1 | CONTINUOUS BIOTRANSFORMATION OF SUBSTITUTED AROMATIC CARBOXYLIC ACIDS TO THEIR SELECTIVE ALDEHYDES AND ALCOHOLS | PRIVI BIOTECHNOLOGIES PRIVATE LIMITED (IN) | 2015-09-10 | — | — | US | claimed |
| EP-2890800-A2 | CONTINUOUS BIOTRANSFORMATION OF SUBSTITUTED AROMATIC CARBOXYLIC ACIDS TO THEIR SELECTIVE ALDEHYDES AND ALCOHOLS | Privi Biotechnologies Pvt. Ltd. (IN) | 2015-07-08 | — | — | EP | claimed |
| WO-2014045299-A2 | CONTINUOUS BIOTRANSFORMATION OF SUBSTITUTED AROMATIC CARBOXYLIC ACIDS TO THEIR SELECTIVE ALDEHYDES AND ALCOHOLS | PRIVI BIOTECHNOLOGIES PRIVATE LIMITED (IN) | 2014-03-27 | — | — | WO | claimed |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2025-08-19 | — | — | US | disclosed |
| CN-118459988-B | High-modulus carbon fiber nylon composite material and preparation method thereof | 烟台奥森制动材料有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118459988-A | High-modulus carbon fiber nylon composite material and preparation method thereof | 烟台奥森制动材料有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-114796204-B | Application of ansa triene compounds in antiviral infection medicines and preparation method thereof | 中国人民解放军海军军医大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-116354837-A | Preparation method of 3, 5-diamine benzoic acid | 江苏聚由新材料科技有限公司 | 2023-06-30 | — | — | CN | disclosed |
| US-20230099912-A1 | BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-03-30 | — | — | US | disclosed |
| EP-0831845-A4 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0831845-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | Elizanor Biopharmaceuticals, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0603650-B1 | 3,5-Substituted amino benzoylguanidines, process for their preparation, their use as medicine or diagnostic agent, as well as a medicine containing them | HOECHST AG (DE) | 1997-04-02 | — | — | EP | disclosed |
| WO-1996040156-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5516805-A | 3,5-substituted aminobenzoylguanidines, their use as a medicament or diagnostic and medicament containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-05-14 | — | — | US | disclosed |
| EP-0603650-A1 | 3,5-Substituted amino benzoylguanidines, process for their preparation, their use as medicine or diagnostic agent, as well as a medicine containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-29 | — | — | EP | disclosed |
| US-4104049-A | Chlorine-substituted vinylaminobenzoic acid compounds and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | JAK2, STAT3, STAT5A | TPMT 944/4885HCAR1 1903/4885CYP3A4 1357/4885 |
| US-20230099912-A1 | BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF | JAK2, STAT3, STAT5A | TPMT 944/4885HCAR1 1903/4885CYP3A4 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.